Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride.

Muller RL, Gerber L, Moreira DM, Andriole G Jr, Hamilton RJ, Fleshner N, Parsons JK, Freedland SJ.

Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA.

Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.

Evangelista L, Guttilla A, Zattoni F, Muzzio PC, Zattoni F.

Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy.

Is an initial saturation prostate biopsy scheme better than an extended scheme for detection of prostate cancer? A systematic review and meta-analysis.

Jiang X, Zhu S, Feng G, Zhang Z, Li C, Li H, Wang C, Xu Y.

Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, People's Republic of China.

The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis.

Weight CJ, Kim SP, Jacobson DJ, McGree ME, Boorjian SA, Thompson RH, Leibovich BC, Karnes RJ, St Sauver J.

University of Minnesota, Department of Urology, Minneapolis, USA.

Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis.

Abdollah F, Suardi N, Cozzarini C, Gallina A, Capitanio U, Bianchi M, Sun M, Fossati N, Passoni NM, Fiorino C, Di Muzio N, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A.

Serum isoform [-2]pro derivatives significantly improve prediction of prostate cancer at initial biopsy in a total range of 2-10 ng/ml: a multicentric European study.